1. O-014Regorafenib Dose Optimization Study (ReDOS): Randomized phase II trial to evaluate escalating dosing strategy and pre-emptive topical steroids for regorafenib in refractory metastatic colorectal cancer (mCRC) – An ACCRU Network study. (20th June 2018) Authors: Bekaii-Saab, T; Ou, F; Anderson, D; Ahn, D; Boland, P; Ciombor, K; Jacobs, N; Desnoyers, R; Cleary, J; Meyers, J; Chiorean, E; Pedersen, K; Barzi, A; Sloan, J; McCune, J; Lacouture, M; Lenz, H; Grothey, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy in anterior uveitis of two known steroids and topical tolmetin. Issue 2 (February 1985) Authors: Dunne, J A; Jacobs, N; Morrison, A; Gilbert, D J Journal: British journal of ophthalmology Issue: Volume 69:Issue 2(1985) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗